Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury
Fatih Arslan, Ruenn Chai Lai, Mirjam B Smeets, Lars Akeroyd, Andre Choo, Eissa N E Aguor, Leo Timmers, Harold V van Rijen, Pieter A Doevendans, Gerard Pasterkamp, Sai Kiang Lim, Dominique P de Kleijn, Fatih Arslan, Ruenn Chai Lai, Mirjam B Smeets, Lars Akeroyd, Andre Choo, Eissa N E Aguor, Leo Timmers, Harold V van Rijen, Pieter A Doevendans, Gerard Pasterkamp, Sai Kiang Lim, Dominique P de Kleijn
Abstract
We have previously identified exosomes as the paracrine factor secreted by mesenchymal stem cells. Recently, we found that the key features of reperfusion injury, namely loss of ATP/NADH, increased oxidative stress and cell death were underpinned by proteomic deficiencies in ischemic/reperfused myocardium, and could be ameliorated by proteins in exosomes. To test this hypothesis in vivo, mice (C57Bl6/J) underwent 30 min ischemia, followed by reperfusion (I/R injury). Purified exosomes or saline was administered 5 min before reperfusion. Exosomes reduced infarct size by 45% compared to saline treatment. Langendorff experiments revealed that intact but not lysed exosomes enhanced viability of the ischemic/reperfused myocardium. Exosome treated animals exhibited significant preservation of left ventricular geometry and contractile performance during 28 days follow-up. Within an hour after reperfusion, exosome treatment increased levels of ATP and NADH, decreased oxidative stress, increased phosphorylated-Akt and phosphorylated-GSK-3β, and reduced phosphorylated-c-JNK in ischemic/reperfused hearts. Subsequently, both local and systemic inflammation were significantly reduced 24h after reperfusion. In conclusion, our study shows that intact exosomes restore bioenergetics, reduce oxidative stress and activate pro-survival signaling, thereby enhancing cardiac function and geometry after myocardial I/R injury. Hence, mesenchymal stem cell-derived exosomes are a potential adjuvant to reperfusion therapy for myocardial infarction.
Copyright © 2013 Elsevier B.V. All rights reserved.
Source: PubMed
Tulevat kliiniset tutkimukset
-
October University for Modern Sciences and ArtsRekrytointi
-
Uskudar UniversityEi vielä rekrytointiaTuki- ja liikuntaelimistön kipu | AmmattitauditTurkki (Türkiye)
-
Milton S. Hershey Medical CenterAxogen CorporationEi vielä rekrytointiaKorvarauhasen syöpä | Parotidektomia | Freyn syndrooma | Parotidektomia, potilaan raportoimat tulokset | Korvarauhasen kasvain
-
University of the Italian SwitzerlandUniversita di VeronaEi vielä rekrytointiaOmaishoitajan taakka | Psykologinen ahdistusSveitsi
-
Ain Shams UniversityEi vielä rekrytointiaHip Abductor Insufficiency Following Total Hip Arthroplasty
-
University of CalgaryEi vielä rekrytointiaHypospadias | Ureteropelvic liitoksen tukosKanada
-
Reinovax Biologics Co., LTDEi vielä rekrytointiaA Phase Ⅲ Clinical Trial of an Investigative 24-valent Pneumococcal Polysaccharide Conjugate VaccinePneumokokin aiheuttama infektiotautiKiina
-
Research IncRekrytointiPostoperative Nasal Fibrosis After RhinoplastyKolumbia
-
Abramson Cancer Center at Penn MedicineEi vielä rekrytointia
-
Aligos TherapeuticsEi vielä rekrytointiaTerveet osallistujatYhdysvallat
-
PT Equilab InternationalNestle IndonesiaRekrytointi
-
Stanford UniversityEi vielä rekrytointia